Good afternoon, ladies and gentlemen. I am very excited to have with me today, SÜSS MicroTec SE. SÜSS MicroTec, many of you might know the story already, is a Germany-based company supplying process equipment to the front-end and advanced backend of the semiconductor industry. The group operates through two different segments, Advanced Backend and Photomask Solutions. The company just released Q2 numbers last week. We do cover SUSS, and I will supply a link to our research in the chat box on the lower right-hand corner in a few moments. Deeper insights into the investment case will be shared with us by Sabrina Müller, who is Vice President of Investor Relations and Communications, and Florian Mangold, who is Manager, Investor Relations. We have a presentation of roughly 20 minutes to expect, and then we will dive into the Q&A. In case you do have any questions, please feel free to put them into our chat box on the lower right-hand corner, and we will entertain them during the Q&A session. With all this in mind, we will now hand it over to Florian and Sabrina. Please go ahead. Thank you for the introduction, Holger, and also a very warm welcome from our side. Sorry to all of you who dialed in, or who wanted to join in July, and we postponed at the last minute. This is basically us making good on the promise of joining the conference. We are now hosting this roundtable for you in order to catch you up on the latest around SUSS. We're going to have the presentation with our part first. I'm going to do a quick company introduction. I think most of you are already familiar with SUSS, but for those who are not, it's going to be the short intro. For everyone else, a quick refresher. Sabrina is going to introduce the H1 reporting we just had on last Thursday, talk you through the numbers, and then we'll finish the presentation with a quick look at our Ambition 2030, and then open the floor for questions. As you probably all know and heard from Holger's introduction, we are a key technology supplier for the semiconductor industry. We are addressing customers in the advanced backend, and in the front-end of the semiconductor industry. We are a so-called hidden champion. Not that hidden anymore since we entered the MDAX, frankly speaking. But we started our corporate history 75+ years ago, basically as a distributor of optical inspection tools, and then moved gradually into the semiconductor space. We have a global customer base as the semiconductor industry is global with obviously Asia as one of the most important markets. We are a strategic partner for global semiconductor device manufacturers and foundries. We also cater to the research environment, so we work with universities and R&D facilities across the globe. A quick glance at our company history. I touched upon bits of it already. Founded in 1949 as a redistribution company for optical inspection tools. We then moved into the SEMI sphere in the 1960s where we built the first mask aligner, a tool we custom-developed for Siemens back then. Over the years, we kept the mask. The mask aligner is still one of the tools in our portfolio. Then in 1999 came the initial public offering, when the founding family decided they wanted to move away from the company and give it a broader footing in the public markets. Then we expanded the company through a number of acquisitions where we bought the coating systems through the acquisition of Fairchild Technologies. When we acquired HamaTech, this is when the cleaning expertise for the Photomask Solutions came on board. We acquired PiXDRO with the inkjet printing back in 2020. At the same time, we also started our expansion in Asia, where we created a local production site in Hsinchu, Taiwan, where we started out with 50 employees, which then very rapidly grew into a 450-employee operation, which then, in 2025, led to a new round of investments in Taiwan, where we basically collected all the different sites we had acquired in Taiwan and put them into one building in order to streamline operations and create new headroom in terms of production capacity, because frankly speaking, we could not scale the production in the existing sites, so we brought them all together in one central new site. We also, in 2024, relaunched the whole brand of SUSS, where we also dropped the MicroTec from the name and now operate under the name SUSS or SUSS internationally. Still, the parent company is called SÜSS MicroTec SE, but nonetheless, in the international arena, we're talking about SUSS now. A quick introduction to our board as well. We have three experienced members of our management board. Dr. Cornelia Ballwießer, our CFO. She has a career in the automotive industry and is on board since 2023. Burkhardt Frick, who also joined around the same time. He held various roles at Philips, and lastly, at ASML as a strategic marketing director. Dr. Thomas Rohe, who came from ZEISS. He is with SUSS the longest and also very experienced and well-connected in the semiconductor industry. As Holger already said, we operate in two segments. One is called front-end and one is called back-end. For those of you who are new to semiconductor industry, a quick refresher or a quick introduction to what front-end and back-end actually means. Whenever we talk about the front-end, we are talking about the very, very small feature sizes of today's microchips. Here we are in the nanometer arena. Here we are in the same arena as ASML, for example, who provide lithography tools. Here we are on the most advanced nodes of chip manufacturing. This is something where in the front-end solutions we address with our cleaning solutions, we will talk about that in a bit. Then we have the back-end of the semiconductor industry. Once a chip is fully patterned or a wafer is fully patterned, it is diced, sliced into smaller units, and then integrated into more complex architectures. This happens in the so-called back-end. The structures here are then in the hundreds of nanometers or in the micrometer arena, so a bit rougher structures. This is basically how we or how the semiconductor industry is structured. If you look at the market reportings of, for example, SEMI, where they differentiate between front-end and back-end equipment. This is also how we structure our company. We have the front-end and the back-end as two segments. What do we do in the individual segments? We have four major product lines. In the front-end, it is the so-called Photomask Solutions segment, where we have the cleaning solutions, where we specifically clean photomasks, either in the production process at the mask shop. So when the photomask is written, there are multiple cleaning steps involved, where you clean contaminations of the photomask in the production processes, and as well as in high volume production, where our photomask cleaning tools sit alongside the ASML tools, who do the patterning with a photomask. Then the photomask gets taken out of the machine every number of cycles, put into our cleaners, cleaned, and then is reinserted into the machine. That is what we do in the front-end. In the Advanced Backend, SUSS historically is more of a wafer handling company, so we do most of our work on the wafer level, not on individual dies, but on the individual, on the wafer level. In the first column here, we have the imaging product line, where we have the mask aligner and the UV projection scanner. Both of these tools are lithography tools for advanced packaging applications. The mask aligner is the legacy tool that is with us since the early 1960s. The UV projection scanner also came through an acquisition to SUSS, and is now used by one of the leading foundries in Taiwan for their CoWoS and CoWoS processes. Then we have the coating segment, and what we do here is basically every photolithography step requires that a photoresist is being placed on the wafer and then spun very quickly in order to create a uniform film of photoresist. This is what we do with our coating solutions. Sabrina will talk about coating in a bit, because obviously this has been a bit of a high runner as of late. Then in the last column, we have the bonding equipment. The bonding is an interesting story because this is one of the parts where we are directly exposed to AI chip production. Whenever you stack an HBM chip, you connect individual dies on top of each other, and in order to do that, you need to grind the backside of a wafer down. In order to do that, the first step you need to do is you need to attach the wafer to a carrier wafer, flip it over, grind off the backside, and then flip it back over and remove the carrier wafer. The gluing of the carrier wafer and the removal of the carrier wafer is called bonding and debonding, and this is obviously a step that has to happen with every wafer that goes into HBM, high-bandwidth memory chips, and thereby AI applications. This is the third part of the business we are addressing. Like I said, and this is going to be my last slide here, we are also working on process development, and we are also working closely with R&D facilities. Here, we have just announced, prior to our H1 figures, that we are creating a new site in Karlsruhe, close to the Karlsruhe Institute of Technology, where we will build over the next couple of years a dedicated research and process development center, where we will, together with academia and our customers, work on the next generation of processes and the next generations of tools, which will position SUSS as one of the leading suppliers for the Advanced Backend in the coming years. So much for the introduction, and with that, I will hand over to Sabrina to guide you through the H1 figures. Thank you, Florian, and good afternoon from my side as well. Maybe for all, or for those who follow SUSS already for a longer time, I am the new face because I joined the company just a couple of weeks ago. But very glad to be here and happy to introduce you to our H numbers, H1 numbers, which we published just a couple, yes, of days ago. Here we are. The key highlights from the H1 numbers were that we really had a very exceptional and strong demand, which drove our order intake of EUR 410 million. With more than EUR 260 million already booked in the second quarter alone, making this quarter the strongest quarter in the company's history. As a result, the order backlog increased to a record of EUR 473.7 million, providing us an improved visibility for the rest of 2026 and already for 2027. What was very encouraging is that the demand was very broad-based. While a large coater order of around EUR 115 million obviously stood out in this area, the activity remained very strong across all product lines, and that really reinforces our confidence that we are seeing a very good improvement in the market environment. Having a look at the sales, well sales reached EUR 202.8 million, and while this was below last year's exceptionally strong level, it was fully in line with what we have expected for 2026. Because we have always seen 2026 as a kind of transition year, starting more slowly before gaining momentum, and then of course, progressing over the course of the year. Profitability is also moving in the right direction. As we can see, gross profit margin remained very strong at 37.2%, which is slightly above our current guidance range. We already saw a meaningful step-up in the EBIT margin between Q1 and Q2, and we will have a slide for that later. The H1 EBIT margin was 7%, not yet within our full year guidance range, but the trend is moving in the right direction. Overall, the first half supports the longstanding view that the market conditions are improving and the visibility is steadily getting better. If I had to summarize the first half in maybe three takeaways, I would put it like that. First, the outlook for the semiconductor industry has improved significantly over the past few months. The industry forecast, especially for the wave of fab equipment spending, has been raised and is, of course, supported by continued investments in the AI infrastructure, advanced packaging, and in the high-performance computing. Secondly, Advanced Backend Solutions continues a lot from these trends, and the demand remains particularly strong for our current product portfolio, which provides us, of course, a very solid foundation for the business. At the same time, customers are also preparing for the adoption of our next-generation technologies. The third message, which is an important one, means that our visibility into the year 2027 has improved meaningfully. That means customers are planning earlier and committing further ahead and increasingly reserving product capacities. As a result, EUR 220 million of our EUR 473.7 million order backlog is already scheduled for delivery in 2027, which gives us a very good starting position for next year. This is a good starting point. Having a look at the Q2, thank you. At the Q2 quarter or a snapshot of the quarter, we see here, it clearly reflects the trajectory we anticipated at beginning of the year because Q2 showed an improvement over Q1 in every metric. That means, as I already mentioned, in Q2, order intake was exceptionally strong and reached EUR 260.7 million, which is a new quarterly record for SUSS. The already mentioned large coater order was, of course, a major contributor. What is equally important to know is that the demand remained healthy, even excluding this order of approximately EUR 150 million. The activity was very broad-based and supported by multiple customers and product categories. On the revenue side, Q1 represented the low point, but sales recovered meaningful in Q2, as you can see. Based on our backlog and project schedules, we continue to expect a stronger second half 2026. That increase in sales is also reflected in profitability. The gross margin reached 38% during the quarter and remains at a very healthy level. More importantly, the EBIT margin improved from 4.3% in Q1 to 9% in Q2. That is the type of operating leverage we would expect. Because as volume increases, fixed costs are absorbed more efficiently and profitability improves accordingly. Let us have a look at both our segments, the Advanced Backend Solutions and the Photomask Solutions. Let us start with ABS in the first line. Here we can see that this segment clearly drove the quarter. The order intake reached almost EUR 229 million, which is an exceptional level. The coater order was an important contributor, but it was not a single project story. As already said, it was very encouraging to see a broad demand and orders across all major product lines, which continue to benefit from increasing advanced packaging solutions. From the market perspective, it is exactly what we want to see, that customers are not only investing in individual process steps, they are rather expanding capacity across the advanced packaging flow, and our broad portfolio allows us to participate in multiple areas of that investment cycle. The sales in the Advanced Backend Solutions segment also recovered strongly and increased from EUR 56 million in Q1 to EUR 95 million in Q2. As already said, as volume improved, profitability followed, and EBIT margin moved back into the double digits. Now let us turn to the Photomask Solutions segment. There, the picture is a bit different. While revenue is still reflecting the softer order intake we saw last year, 2025, the demand itself looks very healthy. We booked EUR 83.8 million of orders in the first half, and this was very well above the prior year period, which supports our confidence in the future revenue development. I think what is also very important for you to understand is the underlying economics, that the business remains attractive and the gross margins are still close to the 40%, as you can see, which reflect the technological differentiation of the portfolio and our strong market position in that segment. Stepping back, I think the key message is very straightforward. Advanced Backend Solutions is currently benefiting from a very supportive investment environment, particularly in the advanced back-end, advanced packaging market. Overall, both segments remain very well-positioned. Coming to our last slide. It is our guidance slide. Looking at our numbers today, which I presented here, or which you have already heard in our earnings call last week and our latest confirmation of the full-year guidance, I would like to highlight a couple of things. Let us start maybe with the margin. As you can see, the gross profit margin remains very resilient at 37.2% for the first half 2026, and it is even slightly above the upper end of the full-year guidance range. While this is very encouraging, we continue to expect product and customer mix effects in the second half of the year. As a result, we maintain our guidance, or we maintained our guidance range of 35%-37%, which we continue to view as appropriate for the full year. Secondly, looking at the EBIT margin, the improvement we saw in Q2 is what we expected as the sales volume recovered. The business has a very high operating leverage. That means that higher sales naturally translate into better fixed cost absorption. At the same time, and this is very important, we continue to invest in our product roadmap or in our R&D activities and in our strategic projects. This is why we maintained the EBIT margin guidance despite improving the trend we have seen in Q2 from Q1 to Q2. Third, and this is a question we get very often, and this is whether the strong order momentum and the growing backlog changed our sales outlook for 2026. The reason why we keep the guidance, or we kept the guidance is, as the year progresses, the window for converting new orders into 2026 revenue becomes increasingly narrow. The demand has strengthened and the visibility has improved, and the order intake has been exceptionally strong. But at the same time, many of the orders were booked in Q2 and are more recently scheduled for delivery in 2027 rather than for conversion into the revenue for this year. Maybe you have seen the backlog bridge we discussed during our earnings call and of our total order backlog of EUR 473.7 million, approximately EUR 240 million are currently scheduled for the delivery in 2026, while roughly EUR 220 million are already earmarked for the financial year 2027. So while the strong order momentum significantly improves the visibility and supports the confidence, it's not fundamentally changed the revenue potential for 2026. This is the reason we continue to expect sales in the range of EUR 425 million- EUR 485 million and the gross profit margin between 35% and 37%, as well as an EBIT margin between 8% and 10%. With that, I wanted to conclude with the chapter of the numbers and hand back to Florian with an outlook. All right. I'm going to keep that very brief for the sake of time so that we have enough possibilities to answer all your questions. You all are probably familiar with the market outlook and Ambition 2030. So we're going to spend only a very few seconds on this slide. Basically, this is something you can experience from your everyday life. The application where semiconductors and sensors are being used are increasing by the day. Be that mobility, social or economic, the number of everyday products where you would, in the end, need one semiconductor is increasing by the day. This is something where we say, "Okay, these tech trends, they are going to persist long after the end of the decade." These are significant drivers for years to come in different variations for different product groups. What does that mean for SUSS? We think, or we gave ourselves a long-term ambition for 2030, of a significantly increased sales range of EUR 750 million- EUR 900 million, a gross profit margin that runs up to the mid-40s, and an EBIT margin above the 20% threshold. This is something which should give you an idea on where we want to develop SUSS as a company over the next couple of years. If you know the historic revenue levels we're coming from, you see that the SUSS of 2030 will be significantly bigger and significantly more profitable. This is basically all I wanted to say on the Ambition 2030. Now I think we jump in the Q&A session and I'll open the floor for the questions. Great. Let's jump into the Q&A session. We do have a few questions already. Thanks for the insights provided so far, Sabrina and Florian. I will start with the first couple of questions that are all surrounding your order intake and where we would see order intake going forward. Some of this you might have already addressed during the presentation that you gave us. So in case you did, a quick reference would be appreciated, and we don't have to dwell too deeply into it. Let me start out with a first question that reads: Should we think about the approximately EUR 140 million- EUR 150 million quarterly order level as a reasonable underlying run rate over the next few quarters? On top of that base, and given your customers capacity expansions, do you expect occasional large-scale projects, awards like the Q2 coater order over the next 12 months? Yeah. Thank you, Abbott. Thank you, Holger. I already saw the question. Obviously, this is an important one, because a lot of attention is drawn to the order intake at SUSS. We've seen that over the H2 of last year, where the order intake was particularly slow. That also created a lot of discussion on whether or not our Ambition 2030 is achievable or not. This is sort of a foreword on order intake. We've seen over the last couple of quarters a strong fluctuation in order intake. Until last Thursday, the EUR 150 million from the first quarter were our strongest quarter. You see the trajectory here. We had EUR 88 million in the first quarter of 2025. The numbers we're now talking about, I think we would have probably earned a solid laugh from the audience if we said, "Okay, this is how Q2 is going to look like." That said, what we are seeing now is that in order to achieve the Ambition 2030, we always said that 2025 is going to be a transition year in terms of sales and orders, and that at some point the improvement needs to materialize that provides the backlog that carries us towards the Ambition 2030. Now speaking about the question here, whether or not the EUR 140 million- EUR 150 million is a reasonable run rate. The issue is, if you look at the Q2, you have one strong order on top of an already strong order book across the board. This is maybe something to keep in mind, that you will always have individual quarters that are very strong in order intake, individual quarters that are weaker in order intake. Let's speculate here. You might see an order intake in Q3 that is significantly higher, perhaps even than the Q2. It could also swing the other way that the Q4, for example, is then lower. What would be probably more meaningful is to think about how does the order book have to look like at the end of the year in order to provide sufficient comfort for 2027. Then if you would assume basically a run rate of EUR 150 million, subtract from that the planned sales we already showed you in the slide, you could walk away with a number that is roughly in that arena. The EUR 140 million-EUR 150 million run rate, that does not seem implausible for an order book of, let's put it to EUR 500 million-EUR 550 million at the end of the year. Still, the gist of it is, it's very tricky to say what is a quarterly run rate in order to model that. I know that's not something analysts like to hear. There will be quarters where we can surprise, like this one, and there will be quarters where there will be disappointment about the order intake. That's basically the best answer we can give you. Great. A follow-up on that. Two customers in 2025 contributed roughly 39% to sales, roughly EUR 112 million and EUR 84 million respectively. Where do you expect that concentration to sit in 2027 once the large coater order converts? Is there a ceiling that you have in mind for individual single customers? The question of the share an individual customer could take in 2027 obviously depends on how our forecast for the year is going to look like. This is not something we've communicated, but when you basically take the big coater order we received and then take the current consensus, you could end up in a range where you would see the customer or the share of all that this customer has with SUSS in this year. That's basically an arithmetic exercise, but we cannot really give you any significant color on that, as we don't have a forecast for 2027 out. In terms of customer concentration, what SUSS has been doing under the strategy that Burkhardt Frick implemented or took over and then implemented over the last couple of years is a very strict focus on exactly these big key accounts. We had a very long customer list, and we thinned that down significantly, and we're now focusing on the big players within the industry. With that, obviously, comes a certain customer concentration. I don't think that there will be, or that there is a threshold where we start to feel uncomfortable, because we will always have enough big customers ordering from us. When we look at the customer base over the last couple of years, we see that it's very rare that the big customer in one year is again a big customer in the next year. As the ramp cycles of these customers don't overlap or they don't run over multiple years, we see that the big customer in any given year is a different one than in the last year. This sort of mitigates the risk of the customer concentration. Like I said, it is also an expressed element of the strategy to focus on these bigger projects where you have a meaningful chance to build alike, to streamline orders, to streamline your own suppliers, which should be then also marginally creative in the long run. Thank you. We have talked a lot about order backlog, and we have seen in previous cycles also in the semiconductor industry that orders were not as firm as they appeared. Can you give us a little bit more insights into the EUR 220 million that are already scheduled for 2027? How much would you consider to be effectively firm versus still subject to customer rescheduling or cancellation? The orders enter our order book the moment we have a delivery date for the tools. I am no old-timer at SUSS. I joined the company two years ago, and in this time, I cannot think of a cancellation we had after we had agreed on a delivery date with a customer. So I would say it is obviously not written in stone, because nothing really ever is. But the chances of cancellations, I would put at a very low probability. Great. Are there any penalties if they withdraw from an order, or can you say something on that? Now, that is a question that is very individual for individual customers. Obviously, there are very long-running, very trustful customer relationships where these kind of penalties are usually not applied. These are not the customers we are worried about. The customers we are worried about, they obviously have these kinds of penalties, and they also do prepayments. We are trying to cover our backs there. Generally speaking, that depends a lot on the customer relationship you are having. Thank you. Looking at the current backlog of EUR 220 million, again for 2027, does this imply that the revenue ceiling for the second half 2026 is approximately EUR 250 million-EUR 254 million, and therefore that the midpoint of the full year sales guidance seems to be the more realistic one to assume? That is absolutely correct. This is also something we wanted to communicate very clearly during our conference call. Since we came out with the guidance, a lot of talk with investors and analysts was around when is the timing or when is the point in time where you are going to raise guidance because it was seen as conservative. We stick to our plan. We confirmed the guidance corridor, and we think that now the midpoints of the guidance is the realistic scenario. This has something to do with the order structure. We talked about that in Q1 already, where we see that customers are ordering now but spacing the orders out longer. This is also why we provide so much clarity on the composition of the order book for 2027, because we want to make sure that it is understood that a lot of the order entry is not for delivery in 2026, but it is going to stretch out until 2027. In terms of the guidance, yes, this is the correct view. We will have very limited upside potential in the sales guidance. Thank you. We did talk about the revenue part of it coming from the demand side. Now, there also could be a potential problem on the supply side, and I think at least that's one of the questions that you mentioned in the earnings call, that some parts availability is starting to become an issue which might have an impact on lead times. You haven't seen that thus far, but of course, there always is a potential that that might happen. Which components are becoming constrained, and at what point could this begin to affect 2027 shipments and volumes and respectively margins? The first message here is that this is something we wanted to talk about early because this is something that could potentially materialize. This is not a given yet. The components we're talking about, we are also an integrator where we buy very complex modules or machines from suppliers, which also deliver into other processes and other industrial applications. For example, robotics has been in incredible high demand over the last couple of quarters. So this could be one of the areas where pressure is coming from. We're trying to mitigate that by running a dual sourcing approach. So we have for every component, we have basically two suppliers. But also when you start changing the configuration of the tools, and even if that means you take a component that's exactly the same in functionality and swap the component within the tool, you need to talk to your customer about that and to renegotiate with your customer. If the customer accepts this, then you don't have a problem. But obviously, if the customer says he wants the configuration he initially ordered and you cannot change different components, then you would obviously have the tool as a work in progress for longer and deliver later. The precise effect or the size of the effect is very difficult to estimate because it depends on a lot of moving parts. The question is, will it ever materialize? Then the next question is, would the customers accept changes to the tool or not? We cannot really give you a meaningful size of the effect that it's going to potentially have in 2027. Thank you. Let's continue with another issue, high bandwidth memory, HBM. One of the questions says that you stated that you are in this industry, in the production via bonding and debonding, and there are two questions now from two different people. Are you also involved in the upcoming AI optoelectronic architectural change? You said that you're not seeing momentum from the Korean customer in temporary bonding. Does this look to be more of a timing issue, or are you losing share in the next HBM generation? Okay, let's start with the Korean customer question first. I think this particular Korean customer, still in March, there were ongoing discussions whether or not capacity of that customer is fully utilized. That picture has now changed significantly over the last couple of months. I think Burkhardt already commented in the conference call on that. It could be too early for that customer to say for sure whether or not, and when, and how capacity is ramping again. I wouldn't take that as a sign that we are missing out here, but more as a sign that we are not there yet with this customer. The second question is on the optoelectronic part of the business, or the change to optoelectronics within the packages. First of all, this is a very early-stage discussion. Co-packaged optics is a new trend theme that is emerging, where obviously also SUSS is looking where our portfolio can be applied or where our portfolio even is already applied today. Within the shift towards, for example, glass substrates, this is something where our portfolio, for example, is already relevant today. Because, whether you think of applications like JETx or printing on panel level, where you apply, for example, photoresist or you even apply metallic inks selectively across a panel. That is something where the JETx or the printing tools we are developing would be relevant. Also, the whole coating business is also relevant on glass substrates, which then would at the end of the day, be at some point part of this optoelectronic shift where you would use no longer copper pillars to transmit data through the interposer or through the substrate, but where you would use a light in order to transmit information. For a number of reasons, because you get higher data density, you reduce the thermal stress of the package, and things like that. But this is very early discussion, very early stage, and we are looking into where we are with our portfolio at the moment and where we can position our solutions going forward. Great. Let's continue with the last two questions that I currently see in our chat tool. In case you have additional questions, please feel free to enter them and we will address them. The last two questions that I currently see are regarding your potential production capacity in million euros after the move of your R&D department to Karlsruhe. If you could comment on that. Frankly speaking, you catch me a bit on the left foot here because this is something where we have not yet communicated figures. But I think the more relevant information is that with the build-out of Zhubei, the Zhubei site in Taiwan, we are able to fully achieve the Ambition 2030 goals without any more meaningful CapEx. So anything we create by moving the demo tools from Starnberg to Karlsruhe will create additional capacity we could then use in order, for example, to build tools also in that site. But the move to Karlsruhe is still two years out, so this is why we're not having taken a look on what volume of production capacity the move to Karlsruhe will actually free, so I can't give you a concrete number in million euros here. Last question that I see is the average percentage of sales coming from OSATs in the past and the percentage that you are anticipating for 2026. Okay. This is a very specific breakdown. We would have to get back to you on that, because it's in between different applications between OSATs, or it's basically a reporting theme. We are a reporting metric we are not looking at very strongly, but we are more looking at what process steps are we delivering our tools and then where do we see pockets of demand in terms of the applications or the solutions we are providing. This is not a split that I have right off the bat at my hand here, because frankly speaking, we look at the product lines and what product lines are being sold to the customers. Great. Thank you. I do not see any additional questions in the chat, so given that we have already spent 45 minutes together and shared a lot of insights, I am about to close this call unless anybody is now anxiously typing, which I do not see in my system. I would like to extend my gratitude to you, Sabrina and Florian, for spending the time with us and giving us some insight into this very interesting investment case. We did record this event, so for those of you who might have joined a little later and are interested in catching up, you can find the recording on ResearchHub in a little while. Of course, any additional questions that you might have, I am sure Sabrina and Florian are more than happy to answer just as much as our Analyst, Abbott, who is standing ready to answer questions which might come up. I wish you all a great afternoon. Once again, thank you so much. I just saw somebody typing, but I guess that person stopped. Thank you so much again, and I will now close this call. Thank you. Thank you.